A biosensor consists of a bio-response recognition component. It can be referred to as a bio-component with a transducer that converts a biological response into an electrical signal, which is then amplified, processed, and displayed on the display unit. The combination of the bio-component and the transducer is referred to as the biosensor.
The analysts forecast the global automotive biosensors market to grow at a CAGR of 18.62% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global automotive biosensors market for 2016-2020. To calculate the market size, the report considers the market as derived from its penetration in the overall passenger cars market and with the help of in-house databases on biosensors application in various industry vertical markets.
The market is divided into the following segments based on geography:
- North America
The report, Global Automotive Biosensors Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors
- Jaguar Land Rover
- Freer Logic
- Unprecedented growth rate of global elderly driver population and their vulnerability to crashes owing to weakened motor skills
- Effects of false negatives and positives
- Biosensors as remote healthcare delivery tool
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
- Top-vendor offerings
- Research methodology
- Economic indicators
- Key market highlights
- Value chain analysis
- Product lifecycle
- Regulatory frameworks
- Market overview
- Market size and forecast
- Five forces analysis
- Automotive biosensors market in North America
- Automotive gesture recognition market in Europe
- Automotive biosensors market in rest of the world
PART 08: Market challenges
PART 09: Market trends
PART 10: Vendor landscape
- Prominent vendors
- List of abbreviations
List of Exhibits
Exhibit 01: Scope of market
Exhibit 02: Product offerings
Exhibit 03: Schematic representation of biosensor systems
Exhibit 04: Schematic representation of placement of few biosensors in automobile
Exhibit 05: In-vehicle biosensing capabilities
Exhibit 06: Enablement mode of in-vehicle biosensing capabilities and few comparisons
Exhibit 07: Value chain representation of automotive biosensors market
Exhibit 08: Product lifecycle 2018
Exhibit 09: List of automotive safety standards worldwide
Exhibit 10: Percentage change in road accidents over the period 2000-2020
Exhibit 11: Road crash data (USA) 2014
Exhibit 12: Technology-related enablers for the advent of automotive biosensors
Exhibit 13: Price decline of the automotive biosensors 2015-2020
Exhibit 14: Global automotive biosensors market 2015-2020 ($ millions)
Exhibit 15: Enabling biosensing capability in vehicles by type or mode
Exhibit 16: Five forces analysis
Exhibit 17: Global automotive biosensors market segmentation by geography, 2015-2020
Exhibit 18: Automotive biosensors market in North America 2015-2020 ($ million)
Exhibit 19: Automotive gesture recognition market in Europe 2015-2020 ($ millions)
Exhibit 20: Sales pattern of sports luxury car models of BMW and Audi in Europe, 2013-2016
Exhibit 21: Automotive biosensors market in rest of the world 2015-2020 ($ millions)
Exhibit 22: Alcohol-impaired driving crashes
Exhibit 23: Growth in proportion of global older aged population (2015-2030)
Exhibit 24: Root causes for elderly population to account for high road fatality rates
Exhibit 25: Growth in proportion of drivers' text-messaging while driving
Exhibit 26: Smartphone penetration among drivers
Exhibit 27: Response on in-car infotainment systems (by age groups)
Exhibit 28: Road conditions where drivers use handheld devices
Exhibit 29: Rate of alcohol impairment among drivers involved in road fatalities during day and night, 2014
Exhibit 30: Timeline for various automated driving systems and sensors market
Exhibit 31: A representation of the central display in a car that displays vital parameters
Exhibit 32: A few participants of the ecosystem governing the biosensors market
Exhibit 33: Expectations from the ecosystem participants for a positive impact on the automotive biosensors market
Exhibit 34: Prominent vendors
Exhibit 35: Recent developments
Exhibit 36: Nissan: Brand portfolio
Exhibit 37: Nissan: Business segmentation by revenue 2015
Exhibit 38: Recent developments
Exhibit 39: Recent developments
The author of the report recognizes the following companies as the key players in the global automotive biosensors market: Nissan, Ford, and Volkswagen.
Other Prominent Vendors in the market are: Audi, Medtronic, Cadillac, Daimler, Opel, Jaguar Land Rover, and Freer Logic.
Commenting on the report, an analyst from the research team said: “Biosensors as remote healthcare delivery tool will be a key trend for market growth. The connected car concept is widening the application gamut from telematics services such as stolen vehicle tracking, roadside assistance to even healthcare. The data from biosensors can be communicated to a remote healthcare service provider, and appropriate first aid can be communicated to the driver or other occupants of the vehicle. On account of critical conditions, the sensors may be tuned to immobilize the vehicle and activate an alarm while electronic connectivity enabled gadgets can notify emergency medical services.”
According to the report, one of the key drivers for market growth will be growing maturity of biosensing technologies and increased acceptance in clinical application industry. Biosensors have been widely adopted in the clinical applications segment for monitoring the body's vital signs. It is thus considered a major technological breakthrough in the healthcare industry. The accuracy and efficacy proven in this shall lead to the gradual maturity of the technology in this vertical. This will have a positive impact on the biosensors usage for automotive applications. Similarly, the wider adoption of wearable healthcare devices is yet to reach its full potential. We infer that the impact of biosensors in automotive applications should be felt positively.
Further, the report states that the author views the biosensor products' (current) high-cost as a major challenge. Data-based evidence has indicated that the cost is likely to drastically drop due to mass production as confirmed by several value chain participants involved in sensor technology markets. Automotive OEMs face humongous cost pressures in the wake of dynamic regulations that govern several components within a vehicle. Stringent emission norms, the need for heavy investments in R&D programs, market competition, and evolving customer demands add to rising cost pressures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.